Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 82 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
COSTS AND EXPENSES:      
Research and development $ 3,550 $ 741 $ 12,735
General and administrative 1,619 1,260 16,191
Total operating expenses 5,169 2,001 28,926
Operating Loss (5,169) (2,001) (28,926)
Gain on extinguishment of debt 0 0 8
Other income 0 0 2
Change in fair value of warrant liability 0 0 (1,177)
Interest and other financing costs, net 5 0 (1,799)
NET LOSS $ (5,164) $ (2,001) $ (31,892)
Net loss per common share, basic and diluted (in dollars per share) $ (0.59) $ (0.93)  
Weighted average common shares outstanding, basic and diluted (in shares) 8,718,199 2,159,130